To confirm that hGBP-1 protects ovarian cancer cells from paclitaxel-induced killing, SKOV3 cells lacking hGBP-1 (Figure 1(d)) were transfected with hGBP-1 and treated with paclitaxel. Here, GBP1 is linked to ovarian cancer.